Kimber J, Hickman M, Strang J, Thomas K, Hutchinson S. Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis. Lancet Psychiatry. 2019;6:639–40.
Scotland. Ro. Drug-related deaths in Scotland in 2019. https://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/deaths/drug-related-deaths-in-scotland/2019.
Belzak L, Halverson J. The opioid crisis in Canada: a national perspective. Public Health Agency of Canada; 2018. p. 224–33.
Rudd RA, Aleshire N, Zibbell JE, Gladden M. Increases in drug and opioid overdose deaths—United States, 2000–2014. Morbidity and Mortality Weekly Report. Department of Health and Human Services: Centre for Disease Control (CDC); 2016. p. 1378–82.
Fischer B, Murphy Y, MacPherson D. Illicit drug use and harms, and related interventions and policy in Canada: a narrative review of select key indicators and developments since 2000. Int J Drug Policy. 2016;27:23–35.
Hatt L. The opioid crisis in Canada In: Parlimentary information and research service LaSAD, editor. Ottawa, Canada Library of Parliament Hill Studies; 2022.
Provincial health officer declares public health emergency [press release]. April 14, 2016.
British Columbia Coroners Service. Illicit Drug Toxicity Deaths in BC: January 1, 2011—December 31, 2021. Vancouver BC Coroners Service; 2022.
Palis H, Bélair MA, Hu K, Tu A, Buxton J, Slaunwhite A. Overdose deaths and the COVID-19 pandemic in British Columbia, Canada. Drug and Alcohol Review. 2021.
Lee Y, Lui L, Brietzke E, Liao Y, Lu D, Ho R, et al. Comparing mortality from covid 19 to mortality due to overdose: a micromort analysis. J Affect Disord. 2022;296:514–21.
Kesten J, Holland A, Linton MJ, Family H, Scott J, Horwood J, et al. Living under coronavirus and injecting drugs in bristol (LUCID-B): a qualitative study of experiences of COVID-19 among people who inject drugs Int J Drug Policy. 2021; 98:103391.
BC Coroners Service. Illicit drug toxicity deaths in BC: January 1, 2011 to October, 2021. Vancouver, BC: BC Coroners Service 2021.
Buchman DZ, Leece P, Orkin A. The epidemic as stigma: the bioethics of opioids. J Law Med Ethics. 2017;45(4):607–20.
Tsai AC, Kiang MV, Barnett ML, Beletsky L, Keyes KM, McGinty EE, et al. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med. 2019;16(11):e1002969.
Krüsi A, Wood E, Montaner J, Kerr T. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy. 2010;21(1):4–9.
Lloyd C. Sinning and sinned against: the stigmatization of problem drug users. London: U.K. Drug Policy Commission; 2010.
Ti L, Tzemis D, Buxton JA. Engaging people who use drugs in policy and program development: a review of the literature. Substance Abuse Treat Prev Policy. 2012;7:47.
Lang K, Neil J, Wright J, Dell C, Berenbaum S, ElAneed A. Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers. Substance Abuse Treat Prev Policy. 2013;8(35):1–11.
Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143–55.
Goodman A, Fleming K, Markwick N, Morrison T, Lagimodiere L, Kerr T, et al. “They treated me like crap and I know it was because I was Native”: the healthcare experiences of aboriginal peoples living in Vancouver’s inner city. Soc Sci Med. 2017;178:87–94.
Woodgate R, Zurbaa M, Tennenta P, Cochrane C, Paynec M, Mignoned J. “People try and label me as someone I’m not”: the social ecology of Indigenous people living with HIV, stigma, and discrimination in Manitoba. Can Soc Sci Med. 2017;194:17–24.
Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2–3):188.
Treloar C, Rance J, Backmund M. Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clin Infect Dis. 2013;57:S51–5.
Belle-Isle L, Benoit C, Pauly B. Addressing health inequities through social inclusion: the role of community organizations. Action Res. 2014;12(2):177–93.
Whitley R. Stigma and the social dynamics of exclusion. Res Pract Soc Sci. 2005;1(1):90–5.
Muncan B, Walters SM, Ezell J, Ompad DC. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):1–9.
Domecq JP, Prutsky G, Elraiyah Tea. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14(89).
Shippee ND, Domecq Garces JP, Prutsky Lopez GJ, Wang Z, Elraiyah TA, Nabhan M, et al. Patient and service user engagement in research: a systematic review and synthesized framework. Health Expect. 2013;18(5):1151–66.
Hamilton CB, Hoens AM, Backman CL, McKinnon AM, McQuitty S, English K, et al. An empirically based conceptual framework for fostering meaningful patient engagement in research. Health Expect. 2018;21(1):396–406.
Esmail L, Moore E, Rein A. Evaluating patient and stakeholder engagement in research: moving from theory to practice. J Comp Effect Res. 2015;4(2):133–45.
Canadian Institute of Health Research. Foundations of SPOR. Canadian Institute of Health Research; 2019.
Canadian Institute of Health Research. Strategy for Patient-Oriented Research—Patient Engagement Framework. 2016.
National Institute of Health Research. INVOLVE Supporting public involvement in the NIH, public health and social care research: National Institute of Health Research; 2018. https://www.invo.org.uk/.
About PCORI | PCORI: Patient-Centered Outcomes Research Institute (PCORI); n.d. https://www.pcori.org/about/about-pcori.
Healthcare Delivery and Disparities Research | PCORI: Patient-Centered Outcomes Research Institute (PCORI); 2017. https://www.pcori.org/about/about-pcori/our-programs/healthcare-delivery-and-disparities-research.
Lough S. Need to define patient engagement in research. Can Med Assoc; 2015.
Pauly B, Urbanoski K, Hartney E, Shahram S, Marcellus L, Wallace B, et al. What Is missing from “patient-oriented research?” A view from public health systems and services. Healthc Policy. 2019;15(2):10–9.
Neufeld SD, Chapman J, C Nea. Research 101: a process for developing local guidelines for ethical research in heavily researched communities. Harm Reduct J. 2019;16: 41.
Damon W, Callon C, Wiebe L, Small W, Kerr T, McNeil R. Community-based participatory research in a heavily researched inner city neighbourhood: perspectives of people who use drugs on their experiences as peer researchers. Soc Sci Med. 2017;176:85–92.
Vancouver Area Network of Drug Users (VANDU). VANDU Manifesto for a Drug User Liberation Movement. Vancouver: Vancouver Area Network of Drug Users (VANDU); 2010.
Jozaghi E. The role of drug users’ advocacy group in changing the dynamics of life in the Downtown Eastside of Vancouver. Can J Substance Use. 2014;19(1–2):213–8.
Allman D, Myers T, Schellenberg J, Strike C, Cockerill R, Cavalieri W. Peer networking for the reduction of drug-related harm. Int J Drug Policy. 2006;17(5):402–10.
Friedman SR, de Jong W, Rossi D, Touze G, Rockwell R, Des Jarlais DC, et al. Harm reduction theory: users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. Int J Drug Policy. 2007;18(2):107–17.
Brown G, Crawford S, Perry G-E, Byrne J, Dunne J, Reeders D, et al. Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership. Harm Reduct J. 2019;16:37.
Canadian HIV/AIDS Legal Network. Nothing about us without us- Greater, meaningful involvement of people who use illegal drugs: a public health, ethical, and human rights imperative (Canadian edition). Toronto; 2005.
Jozaghi E, Greer AM, Lampkin H, Buxton JA. Activism and scientific research: 20 years of community action by the Vancouver area network of drug users. Substance Abuse Treat Prev Policy. 2018;13(1):1–9.
Wye SQ, Madden A, Poeder F, McGuckin S, Shying K. A framework for peer education by drug-user organisations. Australian Injecting and Illicit Drug Users League (AIVL); 2006.
Boyd S. Yet they failed to do so: Recommendations based on the experiences of NAOMI research survivors and a call for action. Harm Reduct J. 2013;10(1):1–13.
Souleymanov R, Kuzmanovic D, Marshall Z, Schiem A, Mikki M, Worthington C, et al. The ethics of community-based research with people who use drugs: results from a scoping review. BMC Med Ethics. 2016;17(25).
Lazarus L, Patel S, Shaw A, Leblanc S, Lalonde C, Hladio M, et al. Uptake of community-based peer administered HIV point-of-care testing: findings from the PROUD study. PLoS ONE. 2016;11(12):e0166942.
Pauly B, McCall J, Browne A, Parker J, Mollison A. Toward cultural safety: nurse and patient perceptions of illicit substance use in a hospitalized setting. ANS Adv Nurs Sci. 2015;38(2):121–35.
Urbanoski K, Pauly B, Inglis D, Cameron F, Haddad T, Phillips J, et al. Defining culturally safe primary care for people who use substances: a participatory concept mapping study. BMC Health Serv Res. 2020;20(1):1–12.
Butters J, Erickson PG. Meeting the health care needs of female crack users: a Canadian example. Women Health. 2003;37(3):1.
Chitwood DD, Comerford M, McCoy HV. Satisfaction with access to health care among injection drug users, other drug users, and nonusers. J Behav Health Serv Res. 2002;29(2):189.
McNeil R, Small W, Wood E, Kerr T. Hospitals as a ‘risk environment’: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 2014;105:59–66.
McLaughlin D, McKenna H, Leslie J, Moore K, Robinson J. Illicit drug users in Northern Ireland: perceptions and experiences of health and social care professionals. J Psychiatr Ment Health Nurs. 2006;2006(13):682–6.
Browne AJ, Varcoe C, Smye V, Reimer Kirkham S, Lynam J, Wong S. Cultural safety and the challenges of translating critically oriented knowledge in practice. Nurs Philos. 2009;10:167–79.
Varcoe C, Browne AJ. Culture and cultural safety: Beyond cultural inventories. In: Gregory D, Raymond-Seniuk C, Patrick L, Stephen TC, editors. Fundamentals: perspectives on the art & science of Canadian nursing. Philadelphia: Lippincott Williams & Wilkins; 2014.
Gerlach AJ. A critical reflection on the concept of cultural safety. Can J Occup Ther. 2012;79(3):151–8.
Israel BA, Schulz AJ, Parker EA, Becker AB. Review of Community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health. 1998;19:173–202.
Kim H, Sefcik J, Bradway C. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health. 2017;40(1):23–42.
Sullivan-Bolyai S, Bova C, Harper D. Developing and refining interventions in persons with health disparities: the use of qualitative description. Nurs Outlook. 2005;53(3):127–33.
Caleres G, Strandber EL. Bondesson Aea: drugs, distrust and dialogue—a focus group study with Swedish GPs on discharge summary use in primary care. BMC Fam Pract. 2018;19:127.
Hsieh H, Shannon S. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88.
Merrill J, Rhodes L, Deyo R, Marlatt A, Bradley K. Mutual mistrust in the medical care of drug users. J Gen Intern Med. 2002;17:327–33.
Pauly B. Close to the street: nursing practice with people marginalized by homelessness and substance use. In: Hwang S, Younger M, editors. Homelessness and health in Canada. Ottawa: University of Ottawa Press; 2014.
Virani H, Haines-Saah RJ. Drug decriminalization: a matter of justice and equity not just health. Am J Prev Med. 2020;58(1):164.
Boyd S, Carter C, MacPherson D. More harm than good: drug policy in Canada. Winnipeg: Fernwood Publishing; 2016.
Ostertag S, Wright BRE, Broadhead RS, Altice FL. Trust and other characteristics associated with health care utilization by injection drug users. J Drug Iss. 2006;Fall:953–74.
Kolla G, Strike C. Medicalization under prohibition: the tactics and limits of medicalization in the spaces where people use illicit drugs. Drugs Educ Prev Policy. 2021;28(2):127–37.
van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1):23–35.
Chan Carusone S, Guta A, Robinson S, Tan DH, Cooper C, O’Leary B, et al. “Maybe if I stop the drugs, then maybe they’d care?”-hospital care experiences of people who use drugs. Harm Reduct J. 2019;16(1):16.
Chief Public Health Officer of Canada. Addressing stigma: towards a more inclusive health system. Ottawa: Public Health Agency of Canada; 2019.
Nursing Council of New Zealand. Guidelines for cultural safety, the treaty of Waitangi and Maori health in nursing education and practice. Wellington, New Zealand: Nursing Council of New Zealand; 2005.
Ramsden I. Cultural safety/Kawa Whakaruruhau ten years on: a personal overview. Nurs Prax NZ. 2000;15(1):4–12.
Parry D, Salsberg J, Macaulay AC. A guide to researcher and knowledge-user collaboration in health research. Canadian Institutes of Health Research; 2009.
Lather P. Issues of validity in openly ideological research: Between a rock and a soft place. Interchange. 1986;17(4):63–84.
Greer AM, Pauly B, Scott A, Martin R, Burmeister C, Buxton J. Paying people who use illicit substances or ‘peers’ participating in community-based work: a narrative review of the literature. Drugs Educ Prev Policy. 2019;26(6):447–59.